Atacicept in Subjects With IgA Nephropathy
Clinical trial NCT04716231 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04716231
- Sponsor
- Vera Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-29
- Primary completion
- 2025-05-15
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.